DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.
about
Molecular neurobiology of addiction: what’s all the (Δ)FosB about?Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbensBraking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functionsΔFosB in the nucleus accumbens is critical for reinforcing effects of sexual rewardHub and switches: endocannabinoid signalling in midbrain dopamine neuronsReview. Transcriptional mechanisms of addiction: role of DeltaFosBThe influence of DeltaFosB in the nucleus accumbens on natural reward-related behaviorDistinct patterns of DeltaFosB induction in brain by drugs of abuseVentral Tegmental Area Afferents and Drug-Dependent BehaviorsBrain regional differences in CB1 receptor adaptation and regulation of transcriptionMechanistic insights into nicotine withdrawal.Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nucleiDrug-induced epigenetic changes produce drug toleranceOpiate sensitization induces FosB/ΔFosB expression in prefrontal cortical, striatal and amygdala brain regionsElectroacupuncture decreases excessive alcohol consumption involving reduction of FosB/ΔFosB levels in reward-related brain regionsEnhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortexOrganization of GABAergic synaptic circuits in the rat ventral tegmental areaRole of the midbrain dopaminergic system in modulation of vocal brain activation by social contextAn update on the connections of the ventral mesencephalic dopaminergic complex.Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors.Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cellsDiscovering a new anatomical structure in the brain: implications for neuropsychiatry and therapy.The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses.Assessment of genome and proteome profiles in cocaine abuseCortico-Basal Ganglia reward network: microcircuitry.Reward, addiction, withdrawal to nicotine.Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental areaMicroinfusion of bupropion inhibits putative GABAergic neuronal activity of the ventral tegmental area.Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure.Chronic self-administration of alcohol results in elevated ΔFosB: comparison of hybrid mice with distinct drinking patterns.Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens.GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaineIncreased BOLD activation to predator stressor in subiculum and midbrain of amphetamine-sensitized maternal rats.Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.Modulation of locomotor activation by the rostromedial tegmental nucleus.The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward systemAttenuating GABA(A) receptor signaling in dopamine neurons selectively enhances reward learning and alters risk preference in mice.Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.Cocainomics: new insights into the molecular basis of cocaine addiction.
P2860
Q22241263-D91875B0-5767-4638-A220-1DCE2EBC9C5DQ22248089-4A26FE87-DBA3-45E4-B0B6-7189874EAE0DQ24603596-DC858EF7-C96E-49DD-8D89-2E4275173075Q24617263-2194CF2E-5253-4990-87E1-58B1F975823BQ24623244-FC87A6A0-9219-4E4A-920F-8EE109A5583FQ24642005-BA83C4DF-3E79-4E20-95EF-18426A6FA6DEQ24642930-DCA93DD1-7617-4988-A386-D12F04FCA069Q24645131-E58BE14D-FF34-4DDB-AE08-1708C016A319Q26751118-5460BDB1-16D6-417E-85C5-AB116A994ECFQ26866100-8C8216CC-31EC-4A6A-91BA-26CD577EFA0CQ27687645-D0D9DF2B-8601-4B36-9719-5112AF2C1D1BQ28086942-FD17EC30-44A2-4DEF-A8A2-134DF25112C0Q28469326-680C6F6E-1042-4DA1-900F-EFF5670CC24DQ28476651-8C490605-7771-4B80-902E-3EB6CDF701A7Q28481182-D471B850-0088-42FD-AD56-33CF83F3199FQ28482300-553D4F1A-DAE4-415D-818F-A52BAF2CF595Q28484279-3A1692FC-24C9-444D-AF5B-31732073BC0EQ28756925-4C111AA5-F692-4E05-90E9-3B4D59D6EC6FQ30401219-D00BFBB7-699C-4ADC-AF8B-F9992FE684FAQ30434815-C838DA0D-D10E-4713-9BC5-F02F5E582106Q30471073-33BBEDB0-7F4F-4729-BF17-6AFD6F60F0FDQ30485144-2879A084-CEA3-49C5-B5B9-4D64EA4B9DA0Q30493773-DCCC9CCE-73A2-4007-BC08-05AA7ABED1EFQ33722792-8B8933A2-67E8-4CE1-B5FF-E9245D7F3B6EQ33887052-F1A3CFAD-F190-4E77-A8CE-A10E8AE833BBQ34173418-AFF2A6D4-FFB1-400C-9B9B-D8751FD0C5A4Q34356966-C74782F3-7270-49C4-83E7-674BA97F2B47Q34367958-0BE86823-743B-4123-BE9D-97790947C568Q34442379-9EBAAA77-C25A-4681-B5B0-78C64D0873DBQ34458600-599B388C-FF3B-435F-910B-1DC141E875F0Q34480282-79D99A28-F1BA-4400-97C1-79FFEEA1A0D0Q34528033-422A2480-6A17-4330-834C-362602E9E443Q34700353-362E2235-C760-4A3E-AB22-6ACDD6D10BA1Q34797496-8F8C7B4C-EDD7-45E5-B793-C1C6F3FFDC16Q34906917-8EE7D666-4625-4FD8-BB61-8FC59818B653Q35049827-16F8738B-F559-420A-93DA-75688F731E1CQ35600279-5559934F-B776-45FB-BECD-549AC9B783AAQ35606578-F6855091-06F5-417D-9E65-09BCA632789DQ35646906-5CED46CC-E6AA-4AE8-B9D2-A8FF538BF287Q35663924-08DB4F28-B711-4D20-AF7B-0B25C41E21BA
P2860
DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@en
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@nl
type
label
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@en
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@nl
prefLabel
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@en
DeltaFosB accumulates in a GAB ...... ter psychostimulant treatment.
@nl
P2093
P1476
DeltaFosB accumulates in a GAB ...... fter psychostimulant treatment
@en
P2093
Carlos A Bolaños
David W Self
Deanna L Wallace
Eric J Nestler
Kwang-Ho Choi
Michel Barrot
Paula G Ulery
Scott Edwards
P304
P356
10.1111/J.1460-9568.2005.04110.X
P407
P577
2005-05-01T00:00:00Z